ProductUpdated on 17 February 2026
Zilia Ocular
About
Zilia Ocular is a next-generation retinal imaging and spectroscopy platform designed to measure metabolic biomarkers in the tissues of the eye fundus—starting with oxygen saturation (StO₂). By combining advanced imaging, multi-wavelength spectroscopy, and intelligent software, it provides real-time, quantitative insights into ocular metabolism.
Unlike traditional technologies that detect structural damage once it has already occurred, Zilia Ocular captures functional and metabolic changes that often precede irreversible tissue loss. Because oxygen dysregulation plays a key role in diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration, measuring retinal oxygenation enables earlier detection, improved risk assessment, and more personalized treatment monitoring.
As the first retinal camera designed to assess oxygen saturation directly in eye tissue—not just large blood vessels—Zilia Ocular opens the door to a new era of precision diagnostics in ophthalmology, while also expanding opportunities in neurology, cardiology, and pharmaceutical research.
Looking for
- Distribution Partner
- Clinical Partner
Applies to
- Medical Devices
- Diagnostics
Organisation
Similar opportunities
Product
cogvis companion - rethinking remote patient monitoring
- Other
- E-Health
- Medical Devices
- Clinical Partner
- Distribution Partner
Rainer Planinc
CEO & Co-Founder at cogvis
Wien, Austria
Project cooperation
Microgravity-Enabled Organ-on-Chip: Seeking Pharma/Biotech Co-Development Partners
Sebastian Quincha Muñoz
CEO - CeleroSpace at CeleroSpace
Madrid, Spain
Expertise
AI for Medical Imaging and Diagnostics
Robertas Damaševičius
Professor at Kaunas University of Technology
Kaunas, Lithuania